Advanced Enzyme Technologies Ltd. IPO
IPO Timeline
Category-wise Subscription
| Category | Sub (x) | Offered | Bid For | Amt (Cr)* |
|---|---|---|---|---|
| QIB | — | 2,285,091 (50%) | — | ₹20,474 Cr |
| NII (HNI) | — | 685,528 (15%) | — | ₹6,142 Cr |
| Retail | — | 1,599,565 (35%) | — | ₹14,332 Cr |
| Employee | — | 24,691 (1%) | — | ₹22 Cr |
| Σ Total | — | 4,594,875 (100%) | — | ₹411,701 Cr |
Only available investor categories are shown. Amount is auto-calculated when shares offered and issue price are available.
Issue Details
Minimum Investment (Lot-wise)
| Category | Lots | Shares | Amount (₹) |
|---|---|---|---|
| Retail (Min) | 1 | 16 | ₹14,336 |
| Retail (Max) | 13 | 208 | ₹186,368 |
| S-HNI (Min) | 14 | 224 | ₹200,704 |
| B-HNI (Min) | 67 | 1,072 | ₹960,512 |
Financial Statements Amount In Crore
| Metric | 31-Mar-16 | 31-Mar-15 | 31-Mar-14 |
|---|---|---|---|
| Revenue | 295 | 224 | 240 |
| Profit After Tax | 78 | 50 | 20 |
| Total Assets | 452 | 418 | 408 |
Valuation & Key Ratios
Grey Market Premium (GMP)
GMP is an unofficial grey market indicator and does not guarantee actual listing price. Invest at your own risk.
Objects of the Issue
- 1 Investment in Advanced Enzymes USA, the wholly owned subsidiary for repayment/pre-payment of certain loans availed by Advanced Enzymes USA – 40.00
- 2 General corporate purpose – 7.20
Company Overview
Incorporated in 1989, Advanced Enzyme Technologies Ltd is an India based company engaged in research, development, manufacturing and marketing of Healthcare, Nutrition and Bio-Processing products. Information in this paragraph is copied from chittorgarh.com.
Company produces over 400 proprietary products developed from 60 enzymes. Advanced Enzyme operate in two primary business verticals namely Healthcare & Nutrition (human and animal) and Bio-Processing (food and non-food).
Company has 13 patents registered in its name and applications for registration of 4 patents are pending.
Advanced Enzyme is among top 15 companies in enzyme sales in the world and 2nd largest in India. Company has over 20 years of fermentation experience in the production of enzymes. Company offer these products to its more than 700 global customers across 50 countries around the world. Content in this paragraph is copied from chittorgarh.com.
Advanced Enzyme's R&D team consists of over 55 scientists, microbiologists, engineers, food technologists and biotechnologists. Company have four R&D facilities, of which two are located at Thane, and one each at Sinnar and Chino, California.
Competitive strengths of the company:
1. Integrated Company with presence across the Enzyme Value Chain
2. Strong R&D, enzyme development and manufacturing capabilities
3. Specialized Business Model with high entry barriers
4. Diversified Product Portfolio and Wide Customer Base, served by a Strong Sales, Marketing and Distribution network
5. Experienced Promoters and Strong Management Team
6. Financial stability and stable cash flows